Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow PROCEPT BioRobotics Corp

Get SEC filing alerts via email and in your feed for PROCEPT BioRobotics Corp

PRCT

PROCEPT BioRobotics Corp

About PROCEPT BioRobotics Corp

Procept Biorobotics develops advanced surgical robotic systems for minimally invasive urologic procedures, primarily treating benign prostatic hyperplasia (BPH). Its flagship products, AquaBeam and HYDROS systems, utilize proprietary waterjet technology for precise, safe, and durable tissue removal. The company targets hospitals and urologists worldwide, emphasizing clinical evidence, personalized treatment planning, and broad reimbursement support to improve patient outcomes and establish a new standard in BPH surgery.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from PROCEPT BioRobotics Corp

1
1
PROCEPT BioRobotics Corp PROCEPT BioRobotics Reports $83.1 Million Revenue in Q1 2026, Despite Increased Net Loss

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
PROCEPT BioRobotics Corp PROCEPT BioRobotics Reports 37% Revenue Growth to $308.1 Million in Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
PROCEPT BioRobotics Corp PROCEPT BioRobotics Reports 43% Revenue Growth to $83.3 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
PROCEPT BioRobotics Corp PROCEPT BioRobotics Reports 48% Revenue Growth to $79.2 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
PROCEPT BioRobotics Corp PROCEPT BioRobotics Reports 55% Revenue Growth to $69.2 Million in Latest Quarter

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
PROCEPT BioRobotics Corp PROCEPT BioRobotics Reports 66% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments